186 related articles for article (PubMed ID: 33283422)
21. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.
Lo JA; Fisher DE
Science; 2014 Nov; 346(6212):945-9. PubMed ID: 25414302
[TBL] [Abstract][Full Text] [Related]
22. Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
Eberle J; Garbe C; Kroumpouzos G; Orfanos CE
Recent Results Cancer Res; 1995; 139():123-35. PubMed ID: 7597285
[TBL] [Abstract][Full Text] [Related]
23. [Molecular classification and markers of malignant melanoma].
Tímár J; Hársing J; Somlai B
Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
[TBL] [Abstract][Full Text] [Related]
24. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
25. Nucleotide stress responses in neural crest cell fate and melanoma.
Sporrij A; Zon LI
Cell Cycle; 2021 Aug; 20(15):1455-1467. PubMed ID: 34281491
[TBL] [Abstract][Full Text] [Related]
26. Multiple roles of NF1 in the melanocyte lineage.
Larribère L; Utikal J
Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
[TBL] [Abstract][Full Text] [Related]
27. Melanocytes, melanocyte stem cells, and melanoma stem cells.
Lang D; Mascarenhas JB; Shea CR
Clin Dermatol; 2013; 31(2):166-78. PubMed ID: 23438380
[TBL] [Abstract][Full Text] [Related]
28. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
30. Growth control of melanoma cells and melanocytes by cytokines.
Krasagakis K; Garbe C; Zouboulis CC; Orfanos CE
Recent Results Cancer Res; 1995; 139():169-82. PubMed ID: 7597288
[TBL] [Abstract][Full Text] [Related]
31. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
32. Melanomagenesis: overcoming the barrier of melanocyte senescence.
Ha L; Merlino G; Sviderskaya EV
Cell Cycle; 2008 Jul; 7(13):1944-8. PubMed ID: 18604170
[TBL] [Abstract][Full Text] [Related]
33. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
34. Adhesion, migration and communication in melanocytes and melanoma.
Haass NK; Smalley KS; Li L; Herlyn M
Pigment Cell Res; 2005 Jun; 18(3):150-9. PubMed ID: 15892711
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
[TBL] [Abstract][Full Text] [Related]
36. Glutamatergic signaling in cellular transformation.
Teh JL; Chen S
Pigment Cell Melanoma Res; 2012 May; 25(3):331-42. PubMed ID: 22273393
[TBL] [Abstract][Full Text] [Related]
37. Focus on cutaneous and uveal melanoma specificities.
Pandiani C; Béranger GE; Leclerc J; Ballotti R; Bertolotto C
Genes Dev; 2017 Apr; 31(8):724-743. PubMed ID: 28512236
[TBL] [Abstract][Full Text] [Related]
38. Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study.
Loir B; Pérez Sánchez C; Ghanem G; Lozano JA; García-Borrón JC; Jiménez-Cervantes C
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1083-92. PubMed ID: 10644013
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of melanocytic lesions in a family with an inherited BAP1 mutation.
O'Shea SJ; Mitra A; Graham JL; Charlton R; Adlard J; Merchant W; Newton-Bishop JA
J Cutan Pathol; 2016 Mar; 43(3):287-9. PubMed ID: 26458093
[No Abstract] [Full Text] [Related]
40. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]